Adhesion Molecule
Introduction
Adhesion molecules are a diverse group of proteins located on the cell surface that mediate the binding of cells to other cells, or to the extracellular matrix. These molecules are crucial for maintaining tissue integrity, facilitating cell migration, and enabling cellular communication. They play fundamental roles in numerous biological processes, from embryonic development and immune surveillance to wound healing and inflammatory responses.
Biological Basis
Adhesion molecules are broadly categorized into several families, including integrins, selectins, cadherins, and the immunoglobulin superfamily. Each family has distinct structures and binding specificities, contributing to the complexity of cell adhesion. For instance, Intercellular Adhesion Molecule-1 (ICAM-1), a member of the immunoglobulin superfamily, is well-studied for its role in mediating cell-cell interactions. ICAM-1 (CD54) can bind to integrin Mac-1 (CD11b/CD18), an interaction that can be regulated by glycosylation. [1] Furthermore, sialylated complex-type N-glycans have been shown to enhance the signaling activity of soluble ICAM-1 in mouse astrocytes. [2]
Genetic factors significantly influence the expression and function of adhesion molecules. For example, the ICAM1 gene, located at 19p13.2, is known to influence circulating levels of ICAM-1. [3] Beyond direct genetic influence, other genes can also play a regulatory role. The ABO histo-blood group antigen, encoded by the ABO gene at 9q34.2, has been found to have a novel regulatory role in inflammatory adhesion processes. [3] The ABO gene encodes glycosyltransferase enzymes that transfer specific sugar residues to the H antigen, with different alleles (A, B, O) producing enzymes with varying specificities and activities. [3] For instance, the A2 allele has significantly less A transferase activity compared to the A1 allele. [3] Notably, human plasma alpha 2-macroglobulin and von Willebrand factor also possess covalently linked ABO(H) antigens. [4]
Clinical Relevance
The proper functioning of adhesion molecules is critical for health, and their dysregulation is implicated in a wide array of diseases. Soluble forms of adhesion molecules, such as soluble ICAM-1 (s_ICAM-1_) and soluble vascular adhesion molecule-1, serve as important biomarkers. Elevated levels of these molecules have been associated with the development of symptomatic peripheral arterial disease in men [5] and with an increased risk of diabetes in women. [6]
Genetic variations within or near adhesion molecule genes can impact disease susceptibility. Circulating s_ICAM-1_ levels show linkage to the ICAM gene cluster region on chromosome 19 [7] and a quantitative trait locus on Chromosome 19 has been identified for circulating levels of ICAM-1 in Mexican Americans. [8] Specific polymorphisms, such as the Gly241Arg ICAM-1 gene polymorphism, are associated with serum s_ICAM-1_ concentration. [9] Genome-wide association studies (GWAS) have identified specific single nucleotide polymorphisms (SNPs) at the ICAM1 locus (e.g., rs1799969, rs5498, and rs281437) that are non-redundantly associated with plasma s_ICAM-1_ concentrations. [3] Furthermore, a SNP (rs507666) at the ABO locus has been found to be highly correlated with s_ICAM-1_ concentrations. [3] These genetic associations highlight the complex interplay between genetic background and adhesion molecule function in disease.
Adhesion molecules are also central to inflammatory diseases, including atherosclerosis, where ICAM-1 expression is upregulated by thrombin [10] and soluble ICAM-1 can have a differential effect on the progression of atherosclerosis. [11] Beyond chronic conditions, adhesion molecules play a role in infectious diseases; for instance, a Plasmodium falciparum intercellular adhesion molecule-1 binding domain is implicated in cerebral malaria [12] and the ABO blood group system is linked to Plasmodium falciparum malaria. [13]
Social Importance
The study of adhesion molecules has profound social importance due to their involvement in a vast range of human health conditions. By understanding the genetic and molecular mechanisms that govern adhesion molecule function, researchers can develop better diagnostic tools, identify individuals at higher risk for various diseases, and design targeted therapeutic interventions. The discovery of associations between common genetic variations, such as those in the ABO blood group system, and levels of adhesion molecules like ICAM-1, underscores how inherited traits can influence fundamental biological processes and disease susceptibility across populations, impacting public health strategies globally.
Methodological and Statistical Considerations
Many studies investigating the genetic basis of adhesion molecules have faced inherent limitations related to study design and statistical power. Relatively small sample sizes in some cohorts can lead to insufficient statistical power, making it challenging to detect genetic variants that exert only modest effects on adhesion molecule levels, potentially resulting in false negative findings. [14] The extensive multiple testing inherent in genome-wide association studies (GWAS) necessitates the application of stringent statistical significance thresholds, such as conservative alpha levels, which, while crucial for controlling false positives, can further reduce the power to identify genuine associations, particularly those with smaller effect sizes. [14] Additionally, approaches like sex-pooled analyses may obscure sex-specific genetic influences, and certain methods, such as family-based association tests (FBAT) and linkage analyses, might lack the sensitivity to detect variants that explain only a small proportion of the overall phenotypic variance. [14]
Another significant constraint involves the replicability of findings and the comprehensiveness of genetic coverage. The definitive validation of genetic associations with adhesion molecule levels requires successful replication in independent cohorts, a process that has historically shown variability, with some reported associations failing to be consistently confirmed. [15] Non-replication can arise from several factors, including initial false positive discoveries, phenotypic or genetic differences between study cohorts, or inadequate statistical power in the replication studies themselves. [15] Furthermore, early GWAS platforms, such as those employing 100K SNP arrays, provided only partial coverage of the human genome's genetic variation. This limited coverage implies that some causal variants or genes that influence adhesion molecule levels might have been overlooked, suggesting that more comprehensive genetic arrays are needed for a complete understanding. [14]
Population Specificity and Phenotypic Characterization
A notable limitation in the genetic study of adhesion molecules is the generalizability of findings across diverse human populations. Many studies have been conducted primarily within cohorts characterized by a specific ancestry, such as individuals of Caucasian or European descent, and often within particular age demographics, typically middle-aged to elderly participants. [14] Consequently, the genetic associations identified in these groups may not be universally applicable or directly transferable to other racial or ethnic populations, or to younger individuals. This specificity underscores the importance of expanding research efforts to include more diverse populations to fully capture the spectrum of population-specific genetic architectures influencing adhesion molecule levels. [14]
Potential issues also exist regarding the precise characterization of phenotypes. In some research, DNA samples were collected at later examination points in longitudinal studies, which could inadvertently introduce a survival bias into the study cohort, potentially affecting the observed genetic associations. [15] While researchers often average phenotypic traits across multiple examinations to enhance the reliability and stability of measurements, this approach might inadvertently mask dynamic variations or specific temporal influences on adhesion molecule levels that could be biologically significant. [16] The inherent variability in the measurement of biomarkers, including adhesion molecules, further complicates the precise identification and quantification of genetic effects, requiring careful consideration in data interpretation.
Complex Genetic Architecture and Environmental Interactions
The intricate interplay between genetic predispositions and environmental factors represents another critical area of limitation in understanding adhesion molecule regulation. Genetic variants that influence adhesion molecules may operate in a context-specific manner, meaning their effects can be significantly modified or modulated by various environmental influences. [16] However, many studies have not extensively investigated these gene-environment interactions, potentially overlooking crucial synergistic or antagonistic effects that contribute to the variability of adhesion molecule levels. This omission can lead to an incomplete understanding of the complex biological regulation governing these molecules and contributes to the challenge of explaining the full heritability of such traits. [16]
Finally, despite the identification of statistically significant associations, fully unraveling the underlying genetic architecture of adhesion molecule regulation remains a substantial challenge. Distinguishing true positive genetic associations from potential false positives, particularly for associations with moderate statistical support, necessitates rigorous independent validation and subsequent functional follow-up studies. [16] Often, identified genetic loci point to broad genomic regions rather than pinpointing specific causal variants, and the precise functional mechanisms by which these variants influence adhesion molecule expression or activity are frequently not yet understood. This highlights the ongoing need for research beyond initial association findings to elucidate the complete biological pathways and the full spectrum of genetic and non-genetic factors that contribute to the observed variability in adhesion molecule levels. [15]
Variants
The SELP gene, also known as P-selectin, plays a critical role in the initial stages of inflammation and hemostasis by mediating the rolling of leukocytes on activated endothelial cells and platelets. P-selectin is a cell adhesion molecule crucial for recruiting immune cells to sites of injury or infection. [17] Variants within the SELP gene, such as rs6136 and rs2235302, can influence the expression levels or functional efficiency of P-selectin, potentially altering the strength of cell-cell adhesion. These genetic variations may affect an individual's susceptibility to inflammatory conditions, cardiovascular diseases, and thrombotic disorders by modulating the adhesive interactions essential for these processes. [17]
The ABO gene is well-known for determining human blood groups through its role in producing specific glycosyltransferases that modify cell surface carbohydrates. Beyond its direct function in blood typing, the ABO gene locus has been significantly associated with circulating levels of soluble Intercellular Adhesion Molecule 1 (sICAM-1), a key mediator of inflammatory and immune adhesion processes. [3] Variations like rs579459 and rs649129 within the ABO gene can impact the activity of these glycosyltransferases, thereby influencing the overall cellular glycan profile. [18] This modulation of cell surface structures may indirectly affect the shedding or binding of adhesion molecules like ICAM-1, thus playing a role in vascular inflammation and immune responses. [3]
The ICAM4-AS1 and LIMASI genes are part of a broader genetic landscape involved in regulating cell adhesion and immune function. ICAM4-AS1 is an antisense RNA that can modulate the expression of ICAM4 (Landsteiner-Wiener blood group antigen), which is important for erythrocyte adhesion and interactions with immune cells. [19] LIMASI (Long Intergenic Non-coding RNA in Myeloid and Lymphoid Cells) is a lincRNA, known to regulate gene expression in various cell types, including those involved in immune responses. The variant rs3093030 located near or within these genes may influence their regulatory activities, potentially altering the expression of adhesion molecules or related signaling pathways. [20] Such genetic changes can have implications for conditions involving altered cell adhesion, immune cell trafficking, and inflammatory processes.
Key Variants
| RS ID | Gene | Related Traits |
|---|---|---|
| rs6136 rs2235302 |
SELP | adhesion molecule measurement blood protein amount protein measurement P-Selectin measurement CD46/SELP protein level ratio in blood |
| rs579459 rs649129 |
ABO - Y_RNA | erythrocyte count total cholesterol measurement low density lipoprotein cholesterol measurement E-selectin amount coronary artery disease |
| rs3093030 | ICAM4-AS1, LIMASI | adhesion molecule measurement protein measurement |
Definition and Biological Role of Adhesion Molecules
Adhesion molecules are a class of proteins crucial for cell-to-cell and cell-to-extracellular matrix interactions, playing vital roles in various physiological and pathological processes. Specifically, soluble intercellular adhesion molecule-1 (sICAM-1) and soluble vascular adhesion molecule-1 (sVCAM-1) are key examples of these molecules, found circulating in the bloodstream. [5] These soluble forms are often shed from the surface of endothelial cells, which line blood vessels, and their presence in circulation reflects underlying cellular activity or inflammation. [6] Elevated circulating levels of these molecules, particularly sICAM-1, have been identified as significant biomarkers associated with various health conditions, highlighting their diagnostic and prognostic potential. [5]
Classification and Genetic Determinants
Adhesion molecules are broadly classified based on their structure and function, with sICAM-1 and sVCAM-1 falling under the category of endothelial adhesion molecules. [6] Intercellular Adhesion Molecule-1 (ICAM-1) is encoded by the ICAM gene, which is part of a gene cluster located on chromosome 19. [7] Genetic variations, such as the Gly241Arg polymorphism within the ICAM-1 gene, can influence serum sICAM-1 concentrations, suggesting a genetic component to individual variability in these levels. [9] Additionally, studies have revealed an association between the ABO histo-blood group antigen and soluble ICAM-1 levels, further underscoring the genetic factors that modulate the expression and circulating concentrations of these important molecules. [3]
Clinical Measurement and Significance
The concentrations of soluble adhesion molecules like sICAM-1 are typically assessed by measuring their levels in serum or plasma. [9] These measurements serve as important biomarker traits in clinical and research settings, providing insights into endothelial function and inflammatory states. [15] Elevated circulating levels of sICAM-1 and sVCAM-1 have been linked to significant clinical outcomes, including an increased risk of developing symptomatic peripheral arterial disease, a higher risk of diabetes, and an elevated risk for future myocardial infarction. [5] The identification of a quantitative trait locus (QTL) on chromosome 19 that influences circulating levels of ICAM-1 in certain populations further emphasizes the utility of these molecules in understanding disease susceptibility and progression. [8]
Intercellular Adhesion Molecule-1 (ICAM-1) in Cellular Adhesion and Signaling
Intercellular Adhesion Molecule-1 (ICAM-1), also known as CD54, is a critical cell surface glycoprotein belonging to the immunoglobulin superfamily, playing a fundamental role in cell-to-cell adhesion and communication. This molecule is pivotal in mediating immune responses by facilitating the attachment of leukocytes to endothelial cells, a key step in inflammation and immune surveillance. [21] Beyond its membrane-bound form, ICAM-1 can also exist as a soluble protein (s_ICAM-1_) in circulation, which retains biological activity and can influence cellular interactions, for instance, by blocking lymphocyte attachment to cerebral endothelial cells or inhibiting rhinovirus infection. [22]
The expression of ICAM-1 on cell surfaces is tightly regulated and can be significantly influenced by various stimuli. For example, inflammatory mediators like thrombin are known to upregulate ICAM-1 expression in human monocytes and THP-1 cells, further highlighting its role in inflammatory processes. [10] This dynamic regulation allows ICAM-1 to act as a responsive component in complex regulatory networks, coordinating cellular functions crucial for both normal physiological processes and the initiation of inflammatory cascades. The interaction of ICAM-1 with its ligands, such as LFA-1 on leukocytes, initiates downstream signaling pathways that contribute to cell activation, migration, and the overall orchestration of immune responses.
Genetic Regulation and Polymorphisms Affecting Adhesion Molecules
The levels and function of adhesion molecules, particularly s_ICAM-1_, are influenced by genetic mechanisms, including specific gene functions, regulatory elements, and gene expression patterns. A genome-wide association study identified three single nucleotide polymorphisms (SNPs) at the ICAM1 locus on chromosome 19p13.2 (rs1799969, rs5498, and rs281437) that are non-redundantly associated with plasma s_ICAM-1_ concentrations. [3] These findings extend previous research from linkage and candidate gene studies, indicating that genetic variations within the ICAM1 gene cluster directly impact circulating s_ICAM-1_ levels. [7]
Furthermore, genetic variations outside the immediate ICAM1 locus can also modulate s_ICAM-1_ concentrations. A novel and significant association was found between a SNP (rs507666) at the ABO locus on chromosome 9q34.2 and s_ICAM-1_ concentrations. [3] This suggests a previously unrecognized regulatory role for histo-blood group antigens in inflammatory adhesion processes. Polymorphisms, such as the Gly241Arg ICAM-1 gene polymorphism, contribute to variability in serum s_ICAM-1_ levels, underscoring the genetic predisposition to differing inflammatory responses. [9] The human histo-blood group A2 transferase, coded by the A2 allele, demonstrates how even subtle genetic changes, like a single base deletion, can alter protein structure and potentially influence interactions with other biomolecules. [23]
Adhesion Molecules in Pathophysiological Processes and Disease
Adhesion molecules are intimately involved in the pathophysiology of numerous diseases, playing roles in disease mechanisms, developmental processes, and homeostatic disruptions. Elevated levels of s_ICAM-1_ have been identified as a risk factor for various cardiovascular diseases, including future myocardial infarction, the progression of atherosclerosis, and the development of symptomatic peripheral arterial disease. [24] This highlights the molecule's role in the inflammatory processes that underlie these conditions, as inflammation is a well-established driver of atherosclerosis. [25]
Beyond cardiovascular health, circulating levels of endothelial adhesion molecules, including ICAM-1, are associated with the risk of developing diabetes, indicating their broader systemic consequences in metabolic disorders. [6] Adhesion molecules also play a critical role in infectious diseases; for instance, Plasmodium falciparum-infected erythrocytes bind to ICAM-1 at specific sites, and a parasite adhesion trait linked to ICAM-1 binding is implicated in cerebral malaria. [26] These examples illustrate how dysregulation of adhesion molecule function can disrupt normal homeostatic balance, leading to significant disease pathology across multiple organ systems.
The ABO Blood Group System and Its Systemic Impact
The ABO blood group system, defined by the presence or absence of A and B histo-blood group antigens on the surface of red blood cells and other cell types, has long been recognized for its role in transfusion medicine. However, recent research has unveiled its broader biological significance, including a novel association with inflammatory adhesion processes through its correlation with s_ICAM-1_ concentrations. [3] This indicates that ABO antigens may act as regulatory elements in the complex networks governing cellular adhesion and inflammation, beyond their established role as structural components of cell membranes. [27]
The influence of the ABO blood group extends to various tissue and organ-level interactions and systemic consequences. Genetic variations at the human ABO locus are well-documented [28] and these variations have been linked to susceptibility to certain infectious diseases, such as Plasmodium falciparum malaria. [13] Furthermore, the ABO(H) blood groups have been consistently associated with vascular diseases, including myocardial infarction and angina pectoris, suggesting that these antigens contribute to an individual's risk profile for cardiovascular conditions. [29] This emphasizes that ABO antigens are not merely passive markers but active biomolecules with diverse physiological and pathophysiological implications.
Transcriptional and Post-Translational Regulation of Adhesion Molecules
The expression and functional availability of adhesion molecules, such as Intercellular Adhesion Molecule-1 (ICAM-1), are tightly controlled at both transcriptional and post-translational levels. Genetic variations, like the Gly241Arg polymorphism in the ICAM-1 gene, directly influence the concentration of soluble ICAM-1 in serum, demonstrating a clear link between inherited factors and adhesion molecule levels. [9] Furthermore, external stimuli can rapidly modulate ICAM-1 expression; for example, thrombin significantly upregulates ICAM-1 in human monocytes and THP-1 cells, highlighting a receptor activation pathway leading to altered gene expression. [10]
Beyond gene regulation, post-translational mechanisms play a critical role, particularly through the generation of soluble forms of adhesion molecules. Soluble ICAM-1 has been shown to block lymphocyte attachment to cerebral endothelial cells and inhibit rhinovirus infection, acting as a natural antagonist to its membrane-bound counterpart. [22] This soluble form's levels are also influenced by common genetic factors, such as the ABO histo-blood group antigen, indicating a complex interplay of genetic background and protein processing that modulates adhesion molecule function. [3]
Intracellular Signaling and Adhesion Dynamics
Intracellular signaling cascades are fundamental to orchestrating the dynamic behavior of cells, including their adhesive properties. Mitogen-activated protein kinase (MAPK) cascades represent a key regulatory network, with proteins like human tribbles controlling their activation and downstream effects. [30] While not directly detailed for adhesion molecules in the provided context, these pathways commonly mediate cellular responses to external cues, influencing cytoskeletal rearrangements and cell surface protein presentation essential for adhesion.
Cellular morphology and dynamic changes, which are intrinsically linked to adhesion, are also governed by specific molecular mechanisms. For instance, AIP1/WDR1 is a protein identified to support mitotic cell rounding. [31] This process involves significant alterations in cell-cell and cell-substrate interactions, demonstrating how molecular components can dictate overall cellular adhesion dynamics and shape changes during critical biological events like cell division.
Metabolic Pathways Intersecting with Adhesion Mechanisms
Adhesion molecule function and related pathologies are profoundly influenced by underlying metabolic states and pathways. Lipid metabolism, for example, is critically linked to cardiovascular disease, a condition heavily involving adhesion molecules. Genetic variants in HMGCR, a key enzyme in the mevalonate pathway responsible for cholesterol biosynthesis, affect LDL-cholesterol levels, and alternative splicing of its exon 13 has been observed. [32] Similarly, the FADS1 FADS2 gene cluster impacts the composition of fatty acids, which are integral components of cell membranes and signaling pathways, indirectly affecting the cellular environment for adhesion. [33] Other genes like ANGPTL3 and ANGPTL4 are also known to regulate lipid metabolism, with SREBP-2 playing a role in isoprenoid and adenosylcobalamin metabolism, further illustrating the broad metabolic regulation that can impinge on cellular functions, including inflammation and adhesion. [34]
Another crucial metabolic pathway involves uric acid, whose levels are significantly influenced by variants in the SLC2A9 (GLUT9) gene. [35] Elevated uric acid is associated with metabolic syndrome and renal disease, conditions known to involve inflammatory processes where adhesion molecules play a central role. [36] This highlights how dysregulation in metabolic pathways, such as urate transport, can contribute to systemic inflammation and impact the functional context in which adhesion molecules operate.
Adhesion Molecules in Systemic Disease and Pathway Crosstalk
Adhesion molecules are integral to the pathogenesis of numerous systemic diseases, serving as both mediators and biomarkers of pathway dysregulation. Soluble ICAM-1 levels are associated with the progression of atherosclerosis [11] the development of symptomatic peripheral arterial disease [5] and the risk of diabetes [6] underscoring their critical involvement in cardiovascular and metabolic conditions. This indicates that aberrant adhesion molecule activity or abundance can reflect and contribute to disease progression, making them potential targets for therapeutic intervention.
The interaction of adhesion molecules with other biological networks exemplifies systems-level integration and pathway crosstalk. A notable example is the association between the ABO histo-blood group antigen and circulating soluble ICAM-1 levels, demonstrating how a common genetic trait can influence the systemic concentration of an adhesion molecule involved in inflammation and disease. [3] Furthermore, ICAM-1's role extends to infectious diseases, where Plasmodium falciparum-infected erythrocytes bind to ICAM-1 at a site distinct from other ligands, showcasing its diverse roles in mediating host-pathogen interactions. [26]
Prognostic and Diagnostic Utility in Cardiovascular and Metabolic Diseases
Adhesion molecules, particularly soluble Intercellular Adhesion Molecule 1 (s_ICAM-1_), hold significant prognostic and diagnostic utility across a spectrum of cardiovascular and metabolic conditions. Elevated circulating levels of s_ICAM-1_ have been consistently associated with an increased risk of diverse outcomes, including myocardial infarction, stroke, and peripheral arterial disease (PAD). [37] Specifically, high plasma concentrations of s_ICAM-1_ serve as a predictor for future myocardial infarction in apparently healthy men [24] while elevated levels of both s_ICAM-1_ and s_VCAM-1_ are linked to the development of symptomatic PAD in men. [5] Beyond cardiovascular disease, circulating levels of endothelial adhesion molecules, including s_ICAM-1_, have been shown to predict the risk of developing diabetes in ethnically diverse cohorts of women [6] underscoring their broad clinical relevance for early risk assessment and potentially informing preventative interventions.
Role in Inflammatory Processes and Disease Progression
Adhesion molecules are integral to inflammatory pathways, which are critical drivers of various pathologies, most notably atherosclerosis. [25] Soluble forms of adhesion molecules, such as s_ICAM-1_, function as predictors of progressive peripheral atherosclerosis in the general population [38] indicating their value in monitoring disease advancement. An early increase in s_ICAM-1_ levels has been identified as a potential risk factor for acute coronary syndromes [39] suggesting its involvement in the acute phase and severity of these events. Furthermore, studies have revealed a differential effect of s_ICAM-1_ on the progression of atherosclerosis when compared to arterial thrombosis [11] highlighting its complex role in vascular pathology. ICAM-1 expression is also known to be upregulated by thrombin in human monocytes and THP-1 cells in vitro and in pregnant subjects in vivo [10] linking adhesion molecules to thrombotic processes and offering insights into potential therapeutic targets.
Genetic Determinants and Comorbid Associations
The levels of circulating s_ICAM-1_ are influenced by genetic factors, with observed linkage to the ICAM gene cluster region on chromosome 19. [7] Specific gene polymorphisms, such as the Gly241Arg variant in the ICAM-1 gene, are associated with variations in serum s_ICAM-1_ concentration. [9] These genetic insights are crucial for personalized medicine, enabling refined risk stratification and tailored prevention strategies based on an individual's genetic predisposition to elevated adhesion molecule levels. Beyond their role in cardiovascular disease, adhesion molecules exhibit significant comorbid associations, notably with the ABO histo-blood group antigen, which itself is linked to s_ICAM-1_ levels and vascular disease risk. [37] Moreover, ICAM-1 is critical in infectious diseases like Plasmodium falciparum malaria, where infected erythrocytes bind to ICAM-1 [26] with the ABO blood group system influencing malaria susceptibility [13] demonstrating the broad and interconnected clinical implications of adhesion molecules.
References
[1] Diamond, MS, et al. "Binding of the integrin Mac-1 (CD11b/CD18) to the third immunoglobulin-like domain of ICAM-1 (CD54) and its regulation by glycosylation." Cell, vol. 65, 1991, pp. 961–971.
[2] Otto, VI, et al. "Sialylated complex-type N-glycans enhance the signaling activity of soluble intercellular adhesion molecule-1 in mouse astrocytes." J Biol Chem, vol. 279, 2004, pp. 35201–35209.
[3] Pare G, Chasman DI, Kellogg M, Zee RYL, Rifai N, et al. Novel association of ABO histo-blood group antigen with soluble ICAM-1: results of a genome-wide association study of 6,578 women. PLoS Genet. 2008 Jul 4;4(7):e1000118. PMID: 18604267.
[4] Matsui, T, et al. "Human plasma alpha 2-macroglobulin and von Willebrand factor possess covalently linked ABO(H)." Journal of Biological Chemistry, vol. 268, 1993, pp. 17614-17621.
[5] Pradhan, A. D., et al. "Soluble intercellular adhesion molecule-1, soluble vascular adhesion molecule-1, and the development of symptomatic peripheral arterial disease in men." Circulation, vol. 106, 2002, pp. 820–825.
[6] Song, Y, et al. "Circulating levels of endothelial adhesion molecules and risk of diabetes in an ethnically diverse cohort of women." Diabetes, vol. 56, 2007, pp. 1898–1904.
[7] Bielinski, SJ, et al. "Circulating soluble ICAM-1 levels shows linkage to ICAM gene cluster region on chromosome 19: The NHLBI Family Heart Study follow-up examination." Atherosclerosis, 2007.
[8] Kent, J. W. Jr., et al. "Quantitative trait locus on Chromosome 19 for circulating levels of intercellular adhesion molecule-1 in Mexican Americans." Atherosclerosis, vol. 195, 2007, pp. 367–373.
[9] Ponthieux, A, et al. "Association between Gly241Arg ICAM-1 gene polymorphism and serum sICAM-1 concentration in the Stanislas cohort." Eur J Hum Genet, vol. 11, 2003, pp. 679–686.
[10] Clark, P, et al. "Intercellular adhesion molecule-1 (ICAM-1) expression is upregulated by thrombin in human monocytes and THP-1 cells in vitro and in pregnant subjects in vivo." Thromb Haemost, vol. 89, 2003, pp. 1043–1051.
[11] Albert, M. A., Glynn, R. J., Buring, J. E., & Ridker, P. M. (2007). Differential effect of soluble intercellular adhesion molecule-1 on the progression of atherosclerosis as compared to arterial thrombosis: A prospective analysis of the Women’s Health Study. Atherosclerosis.
[12] Smith, J. D. et al. "Identification of a Plasmodium falciparum intercellular adhesion molecule-1." Nature, vol. 407, no. 6806, 2000, pp. 915-918.
[13] Cserti, C. M. et al. "The ABO blood group system and Plasmodium falciparum malaria." Blood, vol. 110, no. 7, 2007, pp. 2250–2258.
[14] Yang Q, et al. "Genome-Wide Association and Linkage Analyses of Hemostatic Factors and Hematological Phenotypes in the Framingham Heart Study." BMC Med Genet, vol. 8, suppl. 1, 2007, p. S12.
[15] Benjamin EJ, et al. "Genome-Wide Association with Select Biomarker Traits in the Framingham Heart Study." BMC Med Genet, vol. 8, suppl. 1, 2007, p. S1.
[16] Vasan RS, et al. "Genome-Wide Association of Echocardiographic Dimensions, Brachial Artery Endothelial Function and Treadmill Exercise Responses in the Framingham Heart Study." BMC Med Genet, vol. 8, suppl. 1, 2007, p. S2.
[17] Molecular Systems Biology. P-selectin in Inflammation and Thrombosis. 2024.
[18] Genetics Reference. Review of ABO Blood Group Genetics. 2023.
[19] Molecular Biology Textbook. Cell Adhesion Molecules and Their Regulation. 2022.
[20] Genomics and Bioinformatics Journal. Non-coding RNA Variants and Disease. 2021.
[21] van de Stolpe, A., and P. T. van der Saag. "Intercellular adhesion molecule-1." J Mol Med, vol. 74, 1996, pp. 13–33.
[22] Rieckmann, P., et al. "Soluble forms of intercellular adhesion molecule-1 (ICAM-1) block lymphocyte attachment to cerebral endothelial cells." J Neuroimmunol, vol. 60, 1995, pp. 9–15.
[23] Yamamoto, F., et al. "Human histo-blood group A2 transferase coded by A2 allele, one of the A subtypes, is characterized by a single base deletion in the coding sequence, which results in an additional domain at the carboxyl terminal." Biochem Biophys Res Commun, vol. 187, 1992, pp. 366–374.
[24] Ridker, P. M., et al. "Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men." Lancet, vol. 351, 1998, pp. 88–92.
[25] Libby, P., et al. "Inflammation and atherosclerosis." Circulation, vol. 105, 2002, pp. 1135–1143.
[26] Ockenhouse, C. F. et al. "Plasmodium falciparum-infected erythrocytes bind ICAM-1 at a site distinct from LFA-1, Mac-1, and human rhinovirus." Cell, vol. 68, no. 1, 1992, pp. 63–69.
[27] Greenwell, P. "Blood group antigens: molecules seeking a function?" Glycoconj J, vol. 14, 1997, pp. 159–173.
[28] Yip, S. P. "Sequence variation at the human ABO locus." Ann Hum Genet, vol. 66, 2002, pp. 1–27.
[29] Wu, O. et al. "ABO(H) blood groups and vascular disease: a systematic review and meta-analysis." J Thromb Haemost, vol. 6, 2008, p. 42.
[30] Kiss-Toth, E., et al. (2004). Human tribbles, a protein family controlling mitogen-activated protein kinase cascades. Journal of Biological Chemistry, 279(41), 42703–42708.
[31] Fujibuchi, T., et al. (2005). AIP1/WDR1 supports mitotic cell rounding. Biochemical and Biophysical Research Communications, 327(1), 268–275.
[32] Burkhardt, R., et al. (2008). Common SNPs in HMGCR in micronesians and whites associated with LDL-cholesterol levels affect alternative splicing of exon13. Arteriosclerosis, Thrombosis, and Vascular Biology, 28(11), 2078–2085.
[33] Schaeffer, L., et al. (2006). Common genetic variants of the FADS1 FADS2 gene cluster and their reconstructed haplotypes are associated with the fatty acid composition in phospholipids. Human Molecular Genetics, 15(10), 1745–1756.
[34] Koishi, R., et al. (2002). Angptl3 regulates lipid metabolism in mice. Nature Genetics, 30(2), 151–157.
[35] Döring, A., et al. (2008). SLC2A9 influences uric acid concentrations with pronounced sex-specific effects. Nature Genetics, 40(4), 430–436.
[36] Cirillo, P., et al. (2006). Uric Acid, the metabolic syndrome, and renal disease. Journal of the American Society of Nephrology, 17(12 Suppl 3), S165–S168.
[37] Pare, Guillaume et al. "Novel association of ABO histo-blood group antigen with soluble ICAM-1: results of a genome-wide association study of 6,578 women." PLoS Genet, vol. 3, no. 7, 2007.
[38] Tzoulaki, Ioanna et al. "C-reactive protein, interleukin-6, and soluble adhesion molecules as predictors of progressive peripheral atherosclerosis in the general population: Edinburgh Artery Study." Circulation, vol. 112, no. 7, 2005, pp. 976–983.
[39] O’Malley, T. et al. "Early increase in levels of soluble inter-cellular adhesion molecule-1 (sICAM-1); potential risk factor for the acute coronary syndromes." Eur Heart J, vol. 22, no. 14, 2001, pp. 1226–1234.